ClinicalTrials.Veeva
Menu

Find clinical trials for Ovarian Cancer in Louisville, KY

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Ovarian Epithelial Carcinoma
Cancer
Endometrial Cancer
Breast Cancer
Fallopian Tube Cancer
Carcinoma
Triple Negative Breast Cancer

Ovarian Cancer trials near Louisville, KY, USA:

ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer (PRESERVE-004)

efficacy with the combination of a next generation anti-CTLA-4 antibody, ONC-392, and anti-PD-1 antibody, pembrolizumab, in platinum resistant ovarian...

Active, not recruiting
Fallopian Tube Cancer
Ovarian Cancer
Drug: ONC-392
Drug: Pembrolizumab

Phase 2

OncoC4

Louisville, Kentucky, United States and 20 other locations

The purpose of this study is to assess the safety, tolerability, and efficacy of CBX-12 in female subjects with platinum resistant or refractory ovarian...

Enrolling
Refractory Ovarian Carcinoma
Platinum-resistant Ovarian Cancer
Drug: CBX-12

Phase 2

Cybrexa Therapeutics

Louisville, Kentucky, United States and 16 other locations

Olaparib Monotherapy in Patients with BRCA Mutated Ovarian Cancer following First Line Platinum Based Chemotherapy....

Active, not recruiting
Advanced Ovarian Cancer
FIGO Stage III-IV
Drug: Olaparib 300mg tablets

Phase 3

AstraZeneca
AstraZeneca

Louisville, Kentucky, United States and 176 other locations

as "study drug". The study is focused on patients who have advanced ovarian cancer.The aim of the study is to see how safe, tolerab...

Enrolling
Ovarian Cancer
Drug: Bevacizumab
Drug: Sarilumab

Phase 2

Regeneron Pharmaceuticals
Regeneron Pharmaceuticals

Louisville, Kentucky, United States and 23 other locations

This study will evaluate the safety and efficacy of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer (PROC) With C...

Enrolling
Ovarian Cancer
Drug: INCB123667

Phase 2

Incyte
Incyte

Louisville, Kentucky, United States and 81 other locations

Researchers are looking for other ways to treat relapsed high-grade serous ovarian cancer. Relapsed means the cancer came ...

Enrolling
Ovarian Cancer Recurrent
Biological: Pembrolizumab
Biological: Bevacizumab

Phase 1, Phase 2

Merck Sharp & Dohme (MSD)
Merck Sharp & Dohme (MSD)

Louisville, Kentucky, United States and 14 other locations

undergoing prospective ophthalmic evaluation with recurrent ovarian cancer (participants with either platinum-sensitive ovarian...

Enrolling
Recurrent Ovarian Cancer
Folate Receptor-Alpha Positive
Drug: Lubricating Eye Drops
Drug: Prednisolone acetate ophthalmic suspension 1% eye drops

Phase 2

AbbVie
AbbVie

Louisville, Kentucky, United States and 43 other locations

(ZN-c3) in subjects with Platinum-Resistant, High-Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer. Part 2 of the...

Enrolling
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Drug: azenosertib

Phase 2

K-Group Beta

Louisville, Kentucky, United States and 69 other locations

This is a clinical study that has two parts. It is testing a potential new medicine called LY4170156 for people with certain types of ovarian...

Begins enrollment this month
Ovarian Neoplasms
Fallopian Tube Neoplasms
Drug: MIRV
Drug: Paclitaxel

Phase 3

Lilly
Lilly

Louisville, Kentucky, United States and 38 other locations

following response to front-line treatment in newly diagnosed ovarian cancer patients. Response to treatment will be analyzed based...

Active, not recruiting
Epithelial Ovarian Cancer
Fallopian Tube Cancer
Drug: Placebo Oral Tablet
Drug: Nivolumab

Phase 3

pharmaand

Louisville, Kentucky, United States and 237 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems